Sep 16, 2024 8:00 am EDT Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
Sep 4, 2024 4:30 pm EDT Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
Jul 18, 2024 4:30 pm EDT Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
Jul 11, 2024 7:00 am EDT Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
May 14, 2024 7:30 am EDT Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
May 9, 2024 4:05 pm EDT Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
May 6, 2024 4:15 pm EDT Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum